Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022;19(1):16-31.
doi: 10.2174/1567205018666211202143935.

Inflammation in the CNS: Understanding Various Aspects of the Pathogenesis of Alzheimer's Disease

Julia Doroszkiewicz  1 , Piotr Mroczko  2 , Agnieszka Kulczyńska-Przybik  1
Affiliations
Review

Inflammation in the CNS: Understanding Various Aspects of the Pathogenesis of Alzheimer's Disease

Julia Doroszkiewicz et al. Curr Alzheimer Res. 2022.

Abstract

Alzheimer's disease is a progressive and deadly neurodegenerative disorder and one of the most common causes of dementia globally. Current, insufficiently sensitive and specific methods of early diagnosing and monitoring this disease prompt a search for new tools. Numerous literature data have indicated that the pathogenesis of Alzheimer's disease (AD) is not limited to the neuronal compartment but involves various immunological mechanisms. Neuroinflammation has been recognized as a very important process in AD pathology. It seems to play pleiotropic roles, both neuroprotective and neurodegenerative, in the development of cognitive impairment depending on the stage of the disease. Mounting evidence demonstrates that inflammatory proteins could be considered biomarkers of disease progression. Therefore, the present review summarizes the role of some inflammatory molecules and their potential utility in detecting and monitoring dementia severity. This paper also provides a valuable insight into new mechanisms leading to the development of dementia, which might be useful in discovering possible anti-inflammatory treatment.

Keywords: Alzheimer's disease; biomarkers; chemokines; dementia disorders; interleukins; neurodegeneration; neuroinflammation.

PubMed Disclaimer

Figures

Fig. (1)
Fig. (1)
The mechanism of neuroinflammation in healthy and AD brains. (A higher resolution / colour version of this figure is available in the electronic copy of the article).
See this image and copyright information in PMC

References

    1. Lane C.A., Hardy J., Schott J.M. Alzheimer’s disease. Eur. J. Neurol. 2018;25(1):59–70. doi: 10.1111/ene.13439. - DOI - PubMed
    1. WHO. Risk Reduction of cognitive decline and dementia. World Health Organization; 2019. p. 96. Available from: https://www.who.int/publications/i/item/risk-reduction-of-cognitive-decl... - PubMed
    1. Alzheimer’s Association. Alzheimer’s Facts and Figures Report. Available from: https://www.alz.org/alzheimers-dementia/facts-figures.
    1. Clarimón J., Djaldetti R., Lleó A., Guerreiro R.J., Molinuevo J.L., Paisán-Ruiz C., Gómez-Isla T., Blesa R., Singleton A., Hardy J. Whole genome analysis in a consanguineous family with early onset Alzheimer’s disease. Neurobiol. Aging. 2009;30(12):1986–1991. doi: 10.1016/j.neurobiolaging.2008.02.008. - DOI - PMC - PubMed
    1. Muñoz S.S., Garner B., Ooi L. Understanding the role of apoe fragments in alzheimer’s disease. Neurochem. Res. 2019;44(6):1297–1305. doi: 10.1007/s11064-018-2629-1. - DOI - PubMed